RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype by Nielsen, C, Vekemans, J, Lievens, M, Kester, K, Regules, J, Ockenhouse, C

PERISCOPE: road towards effective control of pertussis by Diavatopoulos, D, Mills, K, Kester, K, Kelly, D, Pollard, A, Periscope Consortium

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection by White, M, Bejon, P, Olotu, A, Griffin, J, Riley, E, Kester, K, Ockenhouse, C, Ghani, A

Update on the clinical development of candidate malaria vaccines. by Ballou, W, Arevalo-Herrera, M, Carucci, D, Richie, T, Corradin, G, Diggs, C, Druilhe, P, Giersing, B, Saul, A, Heppner, D, Kester, K, Lanar, D, Lyon, J, Hill, A, Pan, W, Cohen, J

Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria. by Lee, E, Palmer, DR, Flanagan, K, Reece, W, Odhiambo, K, Marsh, K, Pinder, M, Gravenor, M, Keitel, W, Kester, K, Diggs, C, Kaslow, D, Apostolopoulos, V, Ballou, W, Hill, A, Krzych, U, Plebanski, M

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. by Lalvani, A, Moris, P, Voss, G, Pathan, A, Kester, K, Brookes, R, Lee, E, Koutsoukos, M, Plebanski, M, Delchambre, M, Flanagan, K, Carton, C, Slaoui, M, Van Hoecke, C, Ballou, W, Hill, A, Cohen, J

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. by Reece, W, Pinder, M, Gothard, P, Milligan, P, Bojang, K, Doherty, T, Plebanski, M, Akinwunmi, P, Everaere, S, Watkins, K, Voss, G, Tornieporth, N, Alloueche, A, Greenwood, B, Kester, K, McAdam, K, Cohen, J, Hill, A

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. by McConkey, S, Reece, W, Moorthy, V, Webster, D, Dunachie, S, Butcher, G, Vuola, J, Blanchard, T, Gothard, P, Watkins, K, Hannan, C, Everaere, S, Brown, K, Kester, K, Cummings, J, Williams, J, Heppner, D, Pathan, A, Flanagan, K, Arulanantham, N, Roberts, M, Roy, M, Smith, G, Schneider, J, Peto, T

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. by Ockenhouse, C, Sun, P, Lanar, D, Wellde, B, Hall, B, Kester, K, Stoute, J, Magill, A, Krzych, U, Farley, L, Wirtz, R, Sadoff, J, Kaslow, D, Kumar, S, Church, L, Crutcher, J, Wizel, B, Hoffman, S, Lalvani, A, Hill, A, Tine, J, Guito, K, de Taisne, C, Anders, R, Ballou, W